There is absolutely no doubt about how the deferred revenue is treated.
My attempt to discuss this is on a different level - it is about the wording from BIG FY17, it is about metrics not known, is about actual profitabilty.
Big FY17 = -4.2
Company states that in fact, this is +4.2
Leaves 1 million to pay for expenses mostly related to Q3 and Q4 orders.
This could be true and I am beginning to think it most like is. But from there and not to investigate the discrepancies is far from how I invest.
